The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of SARS-CoV2 pandemic on the allogeneic transplant activity in Italy. The pandemic period from 1/3/2020 to 31/7/2020 was compared with the same period in 2019. Overall, in 2020 there was a 2.4% reduction in the number of allo-HCT cases compared to 2019. Interestingly, this deflection did not affect the acute leukemia cases (+5.7% in 2020). The use of peripheral blood-derived stem cells (+10.7%) and cryopreservation (97.4% of the centers) was highly adopted in 2020. Despite the sanitary emergency, almost all of the surveyed centers declared no impact of SARS-CoV2 pandemic on the transplant timing and outcomes, and the sanitary policy was positively evaluated by the majority of centers. The emergency measures ensured that only a minority of the allo-HCT patients had been infected by SARS-CoV2; however, a mortality of 42.1% among the allo-HCT patients hospitalized for COVID-19 was recorded. This survey gives us the information that the GITMO Group reacted positively to the pandemic. Thanks to the emergency strategies, the Italian allo-HCT activity continued safely, showing only a minor deflection and offering the same probability of cure to the transplanted patients. © 2021, The Author(s), under exclusive licence to Springer Nature Limited.
Original languageEnglish
Pages (from-to)2272-2275
Number of pages4
JournalBone Marrow Transplant.
Issue number9
Publication statusPublished - 2021


  • acute leukemia
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • Article
  • clinical practice
  • coronavirus disease 2019
  • cryopreservation
  • emergency health service
  • health care facility
  • health care policy
  • health survey
  • hematologic disease
  • Hodgkin disease
  • hospital patient
  • human
  • Italy
  • medical decision making
  • mortality rate
  • multiple myeloma
  • myelodysplastic syndrome
  • nonhodgkin lymphoma
  • pandemic
  • patient safety
  • peripheral blood stem cell transplantation
  • probability
  • Severe acute respiratory syndrome coronavirus 2
  • telemedicine
  • treatment outcome
  • allotransplantation
  • epidemiology
  • hematopoietic stem cell transplantation
  • stem cell transplantation
  • virus RNA
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute
  • Pandemics
  • RNA, Viral
  • SARS-CoV-2
  • Stem Cell Transplantation
  • Transplantation, Homologous


Dive into the research topics of 'Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey): Bone Marrow Transplantation'. Together they form a unique fingerprint.

Cite this